Hormonal birth control in patients with endometriosis: leveling the turns

Mekan R. Orazov , Viktor E. Radzinskii , Evgenii D. Dolgov , Iuliia G. Abramashvili

For citation:

Abstract

Today, endometriosis is one of the most relevant gynecological disorders. This disorder contributes to the development of a number of adverse effects, from endometriosis-associated infertility to chronic pelvic pain. Taking into account its remarkable prevalence and negative impact on the patients' quality of life, we clearly understand that endometriosis has to be treated! But what should the patients with verified endometriosis do, if they need birth control? Are there any options suitable for the 21st Century Woman, which will let her forget about such a big problem and provide reliable birth control? This is what will be discussed in this paper.

Key words: endometriosis, hormonal contraception, dienogest, pelvic pain.

References

1. Chapron C, Souza C, Borghese B et al. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011; 26 (8): 2028–35.

2. Радзинский В.Е., Оразов М.Р., Орехов Р.Е. Индивидуализированный подход в терапии боли, ассоциированной с эндометриозом. Акушерство и гинекология. 2021; 10: 31–7. DOI: 10.18565/aig. 2021.10.31-37 [Radzinskii V.E., Orazov M.R., Orekhov R.E. Individualizirovannyi podkhod v terapii boli, assotsiirovannoi s endometriozom. Akusherstvo i ginekologiia. 2021; 10: 31–7. DOI: 10.18565/aig.2021.10.31-37 (in Russian).]

3. Оразов М.Р., Орехов Р.Е. Комбинированные оральные контрацептивы при эндометриозе – миф или реальность. Клинический разбор в акушерстве, гинекологии и репродуктологии. 2021; 2. [Orazov M.R., Orekhov R.E. Kombinirovannye oral'nye kontratseptivy pri endometrioze – mif ili real'nost'. Klinicheskii razbor v akusherstve, ginekologii i reproduktologii. 2021; 2 (in Russian).]

4. Национальные медицинские критерии приемлемости методов контрацепции. 2023. [Natsional'nye meditsinskie kriterii priemlemosti metodov kontratseptsii. 2023 (in Russian).]

5. Adamson GD, Kennedy S, Hummelshoj L. Creating solutions in endometriosis: global collaboration through the World Endometriosis Research Foundation. J Endometriosis 2010; 2 (1): 3–6.

6. Байрамова Н.Н., Протасова А.Э., Раскин Г.А. и др. Структура злокачественных новообразований у больных эндометриозом: данные эпидемиологического исследования. Журнал акушерства и женских болезней. 2018; 67 (6): 5–12. DOI: 10.17816/ JOWD6765-12 [Bairamova N.N., Protasova A.E., Raskin G.A. i dr. Struktura zlokachestvennykh novoobrazovanii u bol'nykh endometriozom: dannye epidemiologicheskogo issledovaniia. Zhurnal akusherstva i zhenskikh boleznei. 2018; 67 (6): 5–12. DOI: 10.17816/JOWD6765-12 (in Russian).]

7. Радзинский В.Е., Оразов М.Р., Михалева Л.М., Бекулова М.А. Грани проблемы инфильтративного эндометриоза: от патогенеза к эффективной терапии. Гинекология. 2021; 23 (2): 117–24. [Radzinskii V.E., Orazov M.R., Mikhaleva L.M., Bekulova M.A. Grani problemy infil'trativnogo endometrioza: ot patogeneza k effektivnoi terapii. Ginekologiia. 2021; 23 (2): 117–24 (in Russian).]

8. Wiegratz I et al. Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy. Contraception 2011; 84 (2): 133–43.

9. Laganà AS et al. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci 2019; 20 (22): 5615.

10. Dyson MT, Roqueiro D, Monsivais D et al. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. PLoS Genet 2014; 10: e1004158.

11. Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci 2021; 22 (19): 10554.

12. Fukui A et al. Pelvic endometriosis and natural killer cell immunity. Am J Reprod Immunol 2021; 85 (4): e13342.

13. Melioli G, Semino C, Semino A et al. Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis. Am J Reprod Immunol 1993; 30 (4): 218–27. DOI: 10.1111/j.1600-0897. 1993.tb00623

14. Agostinis C et al. Immunological basis of the endometriosis: the complement system as a potential therapeutic target. Front Immunol 2021; 11: 599117.

15. Aydin GA, Ayvaci H, Koc N et al. The Relationship between Decorin and VEGF in Endometriosis. J Coll Physicians Surg Pak 2021; 31 (11): 1285–90. DOI: 10.29271/jcpsp.2021.11.1285. PMID: 34689484

16. Kim HJ et al. Dienogest May Reduce Estradiol-and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture-and Mouse ModelBased Study. Biomedicines 2022; 10 (11): 2992.

17. Оразов М.Р., Раевская О.А., Москвичева В.С. Перебирая фолианты. Ведение больных эндометриозом: обновленный гайд-лайн ESHRE (2022). Информационный бюллетень. Под ред. В.Е. Радзинского. М.: StatusPraesens, 2022. [Orazov M.R., Raevskaia O.A., Moskvicheva V.S. Perebiraia folianty. Vedenie bol'nykh endometriozom: obnovlennyi gaid-lain ESHRE (2022). Informatsionnyi biulleten'. Pod red. V.E. Radzinskogo. M.: StatusPraesens, 2022 (in Russian).]

18. Тихомиров А.Л. Триггеры и профилактика эндометриоза. Трудный пациент. 2019; 17 (8–9): 13–9. [Tikhomirov A.L. Triggery i profilaktika endometrioza. Trudnyi patsient. 2019; 17 (8–9): 13–9 (in Russian).]

19. Facchin F, Barbara G, Saita E et al. Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynecol 2015; 36 (4): 135–41.

20. Caruso S et al. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrin Invest 2016; 39: 923–31.

21. Karacan T et al. Comparison of the efficacy and tolerability of dienogest and dienogest plus ethinylestradiol on endometriosis related-pain. Gyn Obstet Reprod Med 2020; 26 (3): 192–8.

22. Оразов М.Р., Радзинский В.Е., Орехов Р.Е. Эффективность терапии эндометриоз-ассоциированной тазовой боли, резистентной к хирургическому лечению. Гинекология. 2021; 23 (4): 314– 23. DOI: 10.26442/20795696.2021.4.201097 [Orazov M.R., Radzinskii V.E., Orekhov R.E. Effektivnost' terapii endometrioz-assotsiirovannoi tazovoi boli, rezistentnoi k khirurgicheskomu lecheniiu. Ginekologiia. 2021; 23 (4): 314–23. DOI: 10.26442/20795696.2021.4.201097 (in Russian).]

For citation:Orazov M.R., Radzinskii V.E., Dolgov E.D., Abramashvili Iu.G. Hormonal birth control in patients with endometriosis: leveling the turns. Clinical review for general practice. 2023; 4 (3): 28–33. DOI: 10.47407/kr2023.4.3.00219

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice